IRCT20140617018126N2 IRCT 2020-03-29 Tabriz University of Medical Sciences Persian Medicine Products in Covid-19 The Effect of Persian Medicine Products on the Clinical and Laboratory Symptoms of Patients With or Suspected of Covid-19 2020-04-03 anticipated 60 Complete https://irct.ir/trial/46637 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Samples will be randomly assigned to four blocks using Random Allocation Software. Blocking and allocation sequences for concealment will be done by the non-involved researcher (Allocation Concealment).The sample allocation ratio will be Allocation 1:1 and will be divided into two groups of receiving Iranian medicine products and control group (Assignment). Then based on blocks and allocation sequences medication will be given to patients. This is an open-label study and blinding will not happen. 3 Covid-19. Intervention 1: Intervention group: In the intervention group, in addition to the standard treatment, medicinal herbal products will be prescribed. The drug will be given in two combination forms. One in the form of a syrup containing the following medicinal herbs: Zattaria multiflora, Punicagranatum, Marticaria chamomilla, Zizyphus sativa and Mentha spp, and the other in the form of a capsule containing the following medicinal herbs: Rheum officinale, nigella Sativa andnepeta bracteata . In addition to the usual treatment, the intervention group, will receive a capsule every 8 hours and 10 cc of of Iranian medicine syrup every 8 hours for one week. The capsule will be taken at least half an hour after taking the syrup. Intervention 2: Control group: Get standard treatment. No - There is not a plan to make this available Justification or reason for not sharing IPD is No more information